The association between neutrophil gelatinase-associated lipocalin and clinical outcome in chronic heart failure: results from CORONA*

Clinical outcome of renal tubular damage in chronic heart failure†

(2011) Kevin Damman et al.   EUROPEAN HEART JOURNAL

Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: The NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial

(2011) Alan S. Maisel et al.   EUROPEAN JOURNAL OF HEART FAILURE

Renal Dysfunction Is a Stronger Determinant of Systemic Neutrophil Gelatinase–Associated Lipocalin Levels Than Myocardial Dysfunction in Systolic Heart Failure

(2011) Kevin Shrestha et al.   JOURNAL OF CARDIAC FAILURE

Neutrophil Gelatinase-Associated Lipocalin

(2010) Tomas M. Eagan et al.   CHEST

Heart Failure, Chronic Kidney Disease, and Biomarkers

(2010) Yoshitaka Iwanaga et al.   CIRCULATION JOURNAL

Lipocalin-2/Neutrophil Gelatinase-B Associated Lipocalin Is Strongly Induced in Hearts of Rats With Autoimmune Myocarditis and in Human Myocarditis

(2010) Limin Ding et al.   CIRCULATION JOURNAL

Renal Function, Health Outcomes, and Resource Utilization in Acute Heart Failure

(2010) Javed Butler et al.   Circulation-Heart Failure

Decreased serum lipocalin-2 levels in human immunodeficiency virus-infected patients: increase during highly active anti-retroviral therapy

(2010) L. Landrø et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

From kidney to cardiovascular diseases: NGAL as a biomarker beyond the confines of nephrology

(2010) D. Bolignano et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate

(2010) K. Damman et al.   HEART

Review: Neutrophil gelatinase-associated lipocalin: A troponin-like biomarker for human acute kidney injury

(2010) PRASAD DEVARAJAN   NEPHROLOGY

Neutrophil Gelatinase-Associated Lipocalin (NGAL): Validation of commercially available ELISA

(2010) Kirsten R. Pedersen et al.   SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION

Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers

(2010) Michael J. Pencina et al.   STATISTICS IN MEDICINE

Effects of Statin Therapy According to Plasma High-Sensitivity C-Reactive Protein Concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)

(2009) John J.V. McMurray et al.   CIRCULATION

Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure

(2009) A. Yndestad et al.   EUROPEAN HEART JOURNAL

Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptide

(2009) Hans Wedel et al.   EUROPEAN JOURNAL OF HEART FAILURE

Neutrophil gelatinase-associated lipocalin (NGAL/Lcn2) is upregulated in gastric mucosa infected with Helicobacter pylori

(2009) Warner Alpízar-Alpízar et al.   VIRCHOWS ARCHIV

Urinary neutrophil gelatinase associated lipocalin (NGAL), a marker of tubular damage, is increased in patients with chronic heart failure

(2008) Kevin Damman et al.   EUROPEAN JOURNAL OF HEART FAILURE

The Local and Systemic Inflammatory Transcriptome after Acute Kidney Injury

(2008) D. N. Grigoryev et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY